# Duloxetine

## Duxetine 30mg

| TAH Drug Code      | [ODUX](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ODUX)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Major depressive disorder, generalized anxiety disorder, diabetic peripheral neuropathy, fibromyalgia.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Dosing             | Major depressive disorder Initial dose 30-60 mg/day. Target: Acute treatment 40 mg/day (20 mg BID) to 60 mg/day (60 mg QD or 30 mg BID). Maintenance treatment 60 mg/day. Max 120 mg/day. Generalized anxiety disorder: Adults and children >=7 years: Initial dose 30 mg/day. Target: 30-60 mg/day. Max 120 mg/day. Diabetic peripheral neuropathy: 60 mg/day QD. Max 120 mg/day. Fibromyalgia: 30-60 mg/day QD. Max 60 mg/day.                                                                                                                                                                                                                                                                                                  |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Contraindications  | Concomitant use with an MAOI, including linezolid or IV methylene blue. Concomitant use with an MAOI within 14 days of discontinuing an MAOI; at least 5 days should elapse after discontinuation of duloxetine before MAOI initiation due to risk of serotonin syndrome.                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Adverse Effects    | Common: Diaphoresis (Up to 6%), Weight loss (Adult, 1% or greater; pediatric, 14-15%%), Constipation (9-10%), Decrease in appetite (Adult, 6-8%; pediatric, 10-15%), Diarrhea (6-9%), Nausea (18-25%), Vomiting (Adult, 3-4%; pediatric, 9-15%), Xerostomia (Adult, 11-14%; pediatric, 2%), Hypersomnia, Sedated (Pediatric, 9%), Somnolence, Fatigue (Pediatric, 5%) Serious: Hypertensive crisis, Increased blood pressure (2%), Myocardial infarction (0.1-1%), Orthostatic hypotension, Syncope, Erythema multiforme, Stevens-Johnson syndrome, Hyponatremia, Gastrointestinal hemorrhage, Hemorrhage, Abnormal, Liver failure, Angle-closure glaucoma, Suicidal thoughts, Serotonin syndrome, Withdrawal symptom (Up to 50%) |
| Pregnancy          | Human Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| More Info          | [UpToDate](https://www.uptodate.com/contents/duloxetine-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |

